Breaking News
Sunday , August 20 2017
Home / Tag Archives: API

Tag Archives: API

Cadila Healthcare plans to raise Rs 1000 crore via QIP: Report

Cadila Healthcare is reportedly planning to raise around Rs 1000 crore through a qualified institutional placement (QIP) of shares. The QIP, a capital-raising tool, is likely to open in the next two-three months. Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ... Read More »

HPRA grants GMP Compliance certificate to Wockhardt’s Shendra facility

The Health Products Regulatory Authority of Ireland (HPRA) has granted Certificate of GMP Compliance to Wockhardt’s Shendra, Aurangabad facility based on inspection performed from February 27, 2017 to March 03, 2017. Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the ... Read More »

Mangalam Drugs gets WHO-Geneva nod for plant at Vapi

Mangalam Drugs & Organics, one of the leading Pharma/API Company has received the final approval from WHO-Geneva for its plant at Unit-2 situated at G.I.D.C, Vapi, in the state of Gujarat. Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, ... Read More »

Natco Pharma gets environment clearance for expansion project in Telangana

Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs. The proposal is to increase the production capacity of 66 Active Pharmaceutical Ingredients (APIs) and API intermediates at a time with research and development activity from 115.5 tonnes per ... Read More »

Wockhardt seeks shareholders’ nod to raise Rs 1000 crore

Wockhardt, one of India’s largest drug makers, is seeking shareholders’ nod to raise up to Rs 1,000 crore via issue of securities. The company is seeking the approval via a postal ballot for raising additional capital by way of one or more public or private offerings including through a qualified ... Read More »

Strides Shasun’s API site at Puducherry gets ‘zero 483’ status

Strides Shasun’s active pharmaceutical ingredients (API) manufacturing site in Puducherry was recently inspected by the United States Food and Drug Administration (US FDA) and the approval was renewed with ‘Zero 483’ status. Over the last month, three facilities were inspected by US FDA and cleared with Zero 483 Status. The ... Read More »

SeQuent’s arm gets USFDA nod for Visakhapatnam API facility

Alivira Animal Health (Alivira), a wholly owned subsidiary of SeQuent Scientific (SeQuent) has received United States Food and Drug Administration (USFDA) approval for its Animal Health API facility at Visakhapatnam, Andhra Pradesh. This 225KL capacity multi-product facility at Vizag was inspected for the first time by USFDA in November 2016 ... Read More »

Cadila Healthcare acquires entire shares held by its subsidiary companies

Cadila Healthcare has acquired all shares held by its subsidiary companies in Zydus Pharmaceuticals USA Inc., USA, Zydus Healthcare USA LLC, Zydus Noveltech USA, Inc. and Bremer Pharma GmbH, Germany and therefore these four entities have become direct overseas subsidiary companies. Cadila Healthcare is part of the Zydus Cadila Group. ... Read More »